Rephonic
Artwork for Hematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Multiple Myeloma
Chronic Lymphocytic Leukemia
CAR T-Cell Therapy
Follicular Lymphoma
Non-Hodgkin Lymphoma
Bispecific Antibodies
Venetoclax
BTK Inhibitors
Myelofibrosis
Clinical Trials
Acute Myeloid Leukemia
Immune Thrombocytopenia
Diffuse Large B-Cell Lymphoma
Chronic Myeloid Leukemia
Mantle Cell Lymphoma
Daratumumab
CAR T Therapy
FDA Approval
Cytokine Release Syndrome
Tyrosine Kinase Inhibitors

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

PublishesTwice weeklyEpisodes545Founded18 years ago
Number of ListenersCategories
Health & FitnessScienceMedicine

Listen to this Podcast

Artwork for Hematologic Oncology Update

Latest Episodes

Featuring perspectives from Dr Mazyar Shadman, including the following topics:

• The CLL17 trial: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL) (0:00)

• The AMPLIFY trial: Fixed-durat... more

YouTube

Featuring perspectives from Dr Mazyar Shadman and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics:

• Case: A man in his mid 40s with chronic lymphocytic leukemia (CLL) receives acalabrutinib/v... more

YouTube

Featuring perspectives from Dr Melissa Alsina, Dr Hans Lee, Dr Sagar Lonial and Dr Paul G Richardson, moderated by Dr Lonial, including the following topics:

• Introduction (0:00)

• Integrating Bispecific Antibodies into the Management of Relapsed/R... more

YouTube

Featuring perspectives from Dr Farrukh T Awan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, moderated by Dr Kahl, including the following topics:

• Introduction: Biology of Non-Hodgkin Lymphoma (NHL) (00:00)

• Current Role of CD20 x CD3 Bisp... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Blood Cancer Talks
Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Blood Podcast
Blood PodcastAmerican Society of Hematology
The Hematologist
The HematologistThe Hematologist

Recent Guests

Farrukh Awan
faculty member presenting on lymphomas and targeted therapies
UT Southwestern
Episode: For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Robin Klebig
physician discussing toxicity management and practical implementation
Mayo Clinic
Episode: For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Mollie Moran
oncology physician providing case-based insights
The Ohio State University
Episode: For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
Ann Lacase
Oncologist presenting cases
Dana-Farber/Brigham and Women's Cancer Center
Episode: Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Jill Sahl
Oncologist presenting cases
Memorial Sloan Kettering Cancer Center
Episode: Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Tony Hunter
Dr. Tony Hunter, Winship Cancer Institute, Emory University
Winship Cancer Institute, Emory University
Episode: Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Abe Yacoub
Dr. Abe Yacoub, University of Kansas Cancer Center
University of Kansas Cancer Center
Episode: Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Mian Hussein
Dr. Mian Hussein, Florida Cancer Specialists
Florida Cancer Specialists
Episode: Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Dr. John Allan
From Weill Cornell Medicine, New York City
Weill Cornell Medicine
Episode: Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit

Host

Dr. Neil Love
Lead interviewer and host across multiple series and episodes, focused on hematology-oncology topics and CME-driven education.

Reviews

4.6 out of 5 stars from 132 ratings
  • A favorite of mine

    Podcast Addict
    5
    ZGDave
    8 days ago
  • A debt of gratitude that cannot be repaid

    That is how I feel about Dr Neil Love and his tireless work in continuing medical education for everyone in the medical field. These podcasts and discussions contained are informative, thought provoking and provide and excellent in depth but quick update in the rapidly ever-changing field of Hematology-Oncology.

    Apple Podcasts
    5
    Bongir
    United States3 years ago
  • Excellent content

    Always informative, always applies to those of us on the ground making difficult daily decisions on management in the community. Often with limited resources.

    Apple Podcasts
    5
    ZomBucker
    United States4 years ago
  • Excellent up to date reviews.

    I

    Apple Podcasts
    5
    IanMack5000
    United States15 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Strong guest expertise and case-driven discussions that translate to clinic work.
Consistently up-to-date with ASH data and real-world takeaways.
High quality, practical updates for everyday decision-making in hematology-oncology.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#53
India/Science
Apple Podcasts
#190
Singapore/Science
Apple Podcasts
#242
Israel/Science

Talking Points

Recent interactions between the hosts and their guests.

Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
Q: What did the Paradigm Trial at ASH show, and what is its relevance for upfront therapy in younger patients?
Paradigm suggested that Aza- Venetoclax-based approaches using A's of N could enable some transplant-eligible patients to reach transplant with potentially better event-free survival and less hospitalization burden compared to intensive chemotherapy, supporting interest in triplet strategies for fit younger patients.
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
Q: What are the key safety considerations with these agents, particularly differentiation syndrome, and how do you manage them in practice?
Differentiation syndrome can occur rapidly, sometimes necessitating prompt steroids and cytoreduction; monitoring tumor burden and early recognition is crucial, with prophylactic steroids in high-burden cases and careful management of QTc prolongation, especially with Revumenib and ZiptoMenem.
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
Q: Could you talk a little bit about how far MENIN inhibitors might extend beyond KMT2A and NPM1 mutant disease?
Data suggest the mechanism may extend to other leukemias with similar transcriptional dependencies, including NUP98 rearrangements, and may involve an MOA that induces differentiation in sensitive transcriptomes, with ongoing efforts to identify predictive signatures such as HOXA9 transcriptome profiles.
Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit
Q: Can myelofibrosis be cured, and what are the advantages of earlier intervention?
The only potentially curative option is bone marrow or stem cell transplantation; JAK inhibitors can meaningfully improve symptoms and survival but are not curative, and earlier intervention—especially in intermediate-risk patients—tends to yield better spleen and symptom responses with possible survival benefits.
Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit
Q: How do you decide between Amplify strategy using Acala with Venetoclax versus the older strategy of Obinutuzumab-Venetoclax?
My view is that all-oral regimens like Acala-venetoclax are easier to deploy and may offer similar efficacy with practical advantages, though data in certain subgroups (e.g., unmutated IGHV) may favor back-up options like Obinutuzumab-containing regimens in some scenarios; future data from MAGIC will help clarify this.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Hematologic Oncology Update

What is Hematologic Oncology Update about and what kind of topics does it cover?

A clinically focused, expert-driven series that features one-on-one conversations with hematology-oncology specialists. Episodes center on the latest data and practice implications from ASH meetings, pivotal trials, and emerging therapies (BTK inhibitors, CELMoDs, ITP treatments, bispecific antibodies, CAR-T). Real-world considerations— MRD testing, sequencing of therapies, transplant timing, and toxicity management—are threaded through practical case discussions. Listeners can expect in-depth, practice-oriented insights from leading clinicians affiliated with major cancer centers, with a strong emphasis on translating trials into community care. Notably, the format often blends trial design explanations with real-world anecdotes to illustr... more

Where can I find podcast stats for Hematologic Oncology Update?

Rephonic provides a wide range of podcast stats for Hematologic Oncology Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Hematologic Oncology Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Hematologic Oncology Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Hematologic Oncology Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Hematologic Oncology Update?

Rephonic provides comprehensive predictive audience data for Hematologic Oncology Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Hematologic Oncology Update have?

To see how many followers or subscribers Hematologic Oncology Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Hematologic Oncology Update?

These podcasts share a similar audience with Hematologic Oncology Update:

1. Two Onc Docs
2. Blood Cancer Talks
3. Blood Podcast
4. The Hematologist
5. Gastrointestinal Cancer Update

How many episodes of Hematologic Oncology Update are there?

Hematologic Oncology Update launched 18 years ago and published 545 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Hematologic Oncology Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Hematologic Oncology Update?

Rephonic pulls ratings and reviews for Hematologic Oncology Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Hematologic Oncology Update?

Rephonic provides full transcripts for episodes of Hematologic Oncology Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Hematologic Oncology Update?

Recent guests on Hematologic Oncology Update include:

1. Farrukh Awan
2. Robin Klebig
3. Mollie Moran
4. Ann Lacase
5. Jill Sahl
6. Tony Hunter
7. Abe Yacoub
8. Mian Hussein

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days